Secondary outcomes
hMPV, NL63
CORONAVIRUS, ADVERSE EVENTS, RECRUITMENT, INFLUENZA
Of the 403 participants who had a negative RT-PCR for SARS-CoV-2, RSV was detected in 12 participants (7 subtype A, 5 subtype B), hMPV in 1 participant and seasonal coronavirus in 8 participants (4 species #NL63, 3 #OC43, 1 #229E). No participants tested positive for influenza (subtypes A or B). Among the 260 participants who had a positive RT-PCR for SARS-CoV-2, co-infection with RSV was detected in 2 participants (both subtype B), seasonal coronavirus in 2 (both #OC43) and hMPV in 1.There were no serious adverse events related to study procedures. Three participants were recorded as having been hospitalised within 28 days of a positive COVID-19 test at recruitment with COVID-19 the primary reason for admission, and all were discharged within two weeks. One participant was hospitalised within 28 days of recruitment for an unrelated injury.